Cargando…

Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

Detalles Bibliográficos
Autores principales:	Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079528/ http://dx.doi.org/10.1007/s40261-013-0133-6

Ejemplares similares

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
por: Mago, Rajnish, et al.
Publicado: (2013)

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder
por: Freeman, Marlene P., et al.
Publicado: (2016)

A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder
por: Gommoll, Carl P., et al.
Publicado: (2014)

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
por: Montgomery, Stuart A., et al.
Publicado: (2014)

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials
por: Sambunaris, Angelo, et al.
Publicado: (2014)

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2016)

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
por: Sambunaris, Angelo, et al.
Publicado: (2014)

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study
por: Wesnes, Keith A., et al.
Publicado: (2017)

Erratum: Vol. 66, No. 48
Publicado: (2018)

Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans
por: Chen, Laishun, et al.
Publicado: (2015)

Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
por: Durgam, Suresh, et al.
Publicado: (2019)

Erratum for Euro Surveill. 2016;21(48)
Publicado: (2016)

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study
por: Montgomery, Stuart A., et al.
Publicado: (2014)

Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
por: Durgam, Suresh, et al.
Publicado: (2016)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre, Roger S
Publicado: (2017)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2016)

Erratum to: Guidelines for the labelling of leucocytes with (111)In-oxine
por: Roca, Manel, et al.
Publicado: (2010)

Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
por: Ordoñez-Boschetti, Laura, et al.
Publicado: (2015)

Erratum to ‘Unicondylar Knee Arthroplasty Following a Patellectomy’ [Arthroplasty Today 6 (2020) 48-51]
por: Brauns, Jantine, et al.
Publicado: (2022)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis, Gregory M, et al.
Publicado: (2015)

Erratum to: the ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid AM, et al.
Publicado: (2014)

Erratum: RTN1 mediates progression of kidney disease by inducing ER stress
por: Fan, Ying, et al.
Publicado: (2015)

ERRATUM: Prognostic Implications of Extranodal Extension in Relation to Colorectal Cancer Location
por: Kim, Chan Wook, et al.
Publicado: (2021)

Erratum: Butter Tolerance in Children Allergic to Cow's Milk
por: Yanagida, Noriyuki, et al.
Publicado: (2016)

Erratum to: Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010)

Erratum to: Clearing and Labeling Techniques for Large-Scale Biological Tissues
por: Seo, Jinyoung, et al.
Publicado: (2019)

Erratum to: Panoramic radiographs underestimate extensions of the anterior loop and mandibular incisive canal
por: de Brito, Ana Caroline Ramos, et al.
Publicado: (2016)

Erratum to: Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort
por: Hill, Cian J., et al.
Publicado: (2017)

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
por: Richards, Cynthia, et al.
Publicado: (2018)

Erratum to ““Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy” [Vaccine 38(48) (2020) 7585–7586]
por: Graffigna, Guendalina, et al.
Publicado: (2022)

Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Publicado: (2020)

Fluid management in extensive liposuction: A retrospective review of 83 consecutive patients: Erratum
Publicado: (2018)

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016)

Erratum to: Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?
por: Branchi, Vittorio, et al.
Publicado: (2015)

Erratum to: Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials
por: Thabane, Lehana, et al.
Publicado: (2016)

The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
por: Bruno, Antonio, et al.
Publicado: (2016)

Erratum to: A new F-18 labeled PET tracer for fatty acid imaging
por: Demeure, Fabian, et al.
Publicado: (2014)

A multicenter, open-label, phase III study of Abcertin in Gaucher disease: Erratum
Publicado: (2018)

Erratum for Monsees et al., “Label-Free Raman Microspectroscopy for Identifying Prokaryotic Virocells”
por: Monsees, Indra, et al.
Publicado: (2022)

Erratum: Myc overexpression enhances epicardial contribution to the developing heart and promotes extensive expansion of the cardiomyocyte population
por: Villa del Campo, Cristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_useqctalj7676n2q64jq28ctc0